Biodentine pulpotomy
Sponsors
University Ghent, Cairo University, Cumhuriyet University, NECIBE DAMLA ŞAHIN, Dow University of Health Sciences
Conditions
Extensive Decay in Primary MolarsOral HealthPrimary Tooth PulpotomySymptomatic Irreversible PulpitisSymptomatic Irreversible Pulpitis (SIP)Vital Pulp Therapy
Phase 3
Biodentine Versus White MTA Pulpotomy
CompletedNCT01733420
Start: 2011-10-04End: 2016-02-29Updated: 2021-11-22
Evaluation of Platelet Rich Fibrin Regenerative Pulpotomy in Mature Permanent Molars with Irreversible Pulpitis
Active, not recruitingPACTR202001824413147
Start: 2018-06-01Target: 48Updated: 2026-01-27
Unknown Phase
Pulpotomy in Mature Permanent Molars Using Biodentine Versus MTA
NCT03890835
Start: 2019-05-31End: 2020-05-31Target: 70Updated: 2019-03-26
Postoperative Pain After Full Pulpotomy With TheraCal PT, Biodentin, and MTA
RecruitingNCT06880471
Start: 2024-12-12End: 2025-11-01Target: 51Updated: 2025-03-17
Evaluation of the Success of TheraCal PT in Pulpotomy Treatment of Primary Teeth Using Low-Level Laser Therapy
CompletedNCT07276685
Start: 2023-01-05End: 2025-10-15Updated: 2025-12-11
Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis
RecruitingNCT07483788
Start: 2024-11-02End: 2026-07-31Target: 60Updated: 2026-03-19